Source: Clinical genitourinary cancer. Unidade: FM
Subjects: NEOPLASIAS PROSTÁTICAS, PROSTATECTOMIA, METANÁLISE
ABNT
ILÁRIO, Eder Nisi et al. Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group. Clinical genitourinary cancer, v. 21, n. 1, p. 43-54, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53755. Acesso em: 20 out. 2024.APA
Ilário, E. N., Bastos, D. A., Guglielmetti, G. B., Murta, C. B., Cardili, L., Cordeiro, M. D., et al. (2023). Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group. Clinical genitourinary cancer, 21( 1), 43-54. doi:10.1016/j.clgc.2022.10.009NLM
Ilário EN, Bastos DA, Guglielmetti GB, Murta CB, Cardili L, Cordeiro MD, Pontes Junior J, Coelho RF, Nahas WC. Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group [Internet]. Clinical genitourinary cancer. 2023 ; 21( 1): 43-54.[citado 2024 out. 20 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53755Vancouver
Ilário EN, Bastos DA, Guglielmetti GB, Murta CB, Cardili L, Cordeiro MD, Pontes Junior J, Coelho RF, Nahas WC. Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group [Internet]. Clinical genitourinary cancer. 2023 ; 21( 1): 43-54.[citado 2024 out. 20 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53755